Xponance, Inc. Bio Rad Laboratories, Inc. Transaction History

Xponance, Inc.

$12.3 Billion
Q3 2025

A detailed history of Xponance, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 2,065 shares of BIO stock, worth $647,026. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,065

Previous 2,133 3.19%

Holding current value

$647,026

Previous $514,000 12.65%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$241.95 - $303.82 $16,452 - $20,659	-68 Reduced 3.19%	2,065 $579,000
Q2 2025 Aug 14, 2025	SELL	$216.56 - $256.68 $232,802 - $275,931	-1,075 Reduced 33.51%	2,133 $514,000
Q1 2025 Apr 30, 2025	SELL	$243.0 - $367.0 $4,131 - $6,239	-17 Reduced 0.53%	3,208 $781,000
Q4 2024 Feb 10, 2025	BUY	$313.15 - $374.28 $30,375 - $36,305	97 Added 3.1%	3,225 $1.06 Million
Q3 2024 Nov 12, 2024	BUY	$263.97 - $344.64 $87,110 - $113,731	330 Added 11.79%	3,128 $1.05 Million
Q2 2024 Aug 14, 2024	SELL	$268.26 - $339.48 $70,552 - $89,283	-263 Reduced 8.59%	2,798 $764,000
Q1 2024 May 13, 2024	BUY	$304.11 - $351.99 $99,443 - $115,100	327 Added 11.96%	3,061 $1.06 Million
Q4 2023 Jan 31, 2024	SELL	$269.37 - $365.04 $151,385 - $205,152	-562 Reduced 17.05%	2,734 $882,000
Q3 2023 Oct 23, 2023	BUY	$350.25 - $422.63 $47,283 - $57,055	135 Added 4.27%	3,296 $1.18 Million
Q2 2023 Jul 13, 2023	BUY	$359.49 - $486.4 $75,852 - $102,630	211 Added 7.15%	3,161 $1.2 Million
Q1 2023 Apr 17, 2023	SELL	$418.69 - $503.0 $3,768 - $4,527	-9 Reduced 0.3%	2,950 $1.41 Million
Q4 2022 Jan 23, 2023	BUY	$351.71 - $456.01 $197,661 - $256,277	562 Added 23.45%	2,959 $0
Q3 2022 Oct 24, 2022	BUY	$412.59 - $563.26 $128,728 - $175,737	312 Added 14.96%	2,397 $1 Million
Q2 2022 Aug 02, 2022	SELL	$463.67 - $597.16 $2.03 Million - $2.62 Million	-4,387 Reduced 67.78%	2,085 $1.03 Million
Q1 2022 Apr 20, 2022	SELL	$524.57 - $735.42 $3.34 Million - $4.69 Million	-6,376 Reduced 49.63%	6,472 $3.65 Million
Q4 2021 Jan 31, 2022	BUY	$708.84 - $794.68 $184,298 - $206,616	260 Added 2.07%	12,848 $9.71 Million
Q3 2021 Nov 05, 2021	BUY	$657.71 - $825.77 $4.67 Million - $5.86 Million	7,102 Added 129.46%	12,588 $9.39 Million
Q2 2021 Aug 12, 2021	SELL	$576.64 - $649.04 $708,113 - $797,021	-1,228 Reduced 18.29%	5,486 $3.54 Million
Q1 2021 May 10, 2021	BUY	$547.01 - $662.35 $739,557 - $895,497	1,352 Added 25.21%	6,714 $3.84 Million
Q4 2020 Feb 11, 2021	BUY	$510.68 - $643.45 $2.3 Million - $2.9 Million	4,504 Added 524.94%	5,362 $3.13 Million
Q3 2020 Oct 26, 2020	SELL	$454.43 - $535.6 $15,450 - $18,210	-34 Reduced 3.81%	858 $442,000
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $298,704 - $439,809	892 New	892 $403,000

Others Institutions Holding BIO

# of Institutions

434

Shares Held

19.1M

Call Options Held

10.7K

Put Options Held

35.5K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $7.72B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account